BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed KOD catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:d6909d6c2880959e3ba5@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270201
DTEND;VALUE=DATE:20270202
SUMMARY:KOD P3 readout (est.): PINNACLE
DESCRIPTION:A Phase 3 Study to Evaluate the Efficacy and Safety of Intravit
 real KSI-101 in Participants With Macular Edema Secondary to Inflammation 
 (MESI) - PINNACLE\nNCT06996080 | PHASE3 | RECRUITING | sponsor: Kodiak Sci
 ences Inc\nPrimary completion date (ESTIMATED)\; top-line results usually 
 follow later.\nDate precision: month (shown on the first day)\nTicker KOD 
 (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT06996080\nSc
 heduling/reference data from public records\; dates can move. Not investme
 nt\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06996080
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
